I"<table>
  <tbody>
    <tr>
      <td>Â </td>
      <td>IEEE Standard</td>
      <td>Universal Standard</td>
    </tr>
    <tr>
      <td>Procedure (Static)</td>
      <td>3 pairs of measurements for each subject</td>
      <td>3 pairs of measurements for each subject OR the mean of all beats over a 20 s period for beat-to-beat devices</td>
    </tr>
    <tr>
      <td>Procedure (Test with BP change from calibration point)</td>
      <td>Not specified</td>
      <td>Dataset must include SBP changes of: -30 to -15 (13.6%), -15 to 0 (34.1%), 0-15 (34.1%), 15-30 (13.6%), and DBP changes of: -20 to -10 (13.6%), -10 to 0 (34.1%), 0-10 (34.1%), 10-20 (13.6%)</td>
    </tr>
    <tr>
      <td>Procedure (Test after certain period of time)</td>
      <td>Not specified</td>
      <td>Not specified</td>
    </tr>
    <tr>
      <td>Number of Subjects Required</td>
      <td>85</td>
      <td>20 (phase 1), 25 additional (phase 2)</td>
    </tr>
    <tr>
      <td>Demographics (healthy+diseased)</td>
      <td>adults study shall include â‰¥30% males and â‰¥30% females and shall have â‰¥5% of the reference systolic BP readings â‰¤100 mm Hg, â‰¥5% with â‰¥160 mmHg, and â‰¥20% with â‰¥140 mmHg and â‰¥5% of reference diastolic BP readings â‰¤60 mmHg, â‰¥5% with â‰¥100 mmHg, and â‰¥20% with â‰¥85 mmHg</td>
      <td>equal distribution (5, â‰¥6) of healthy, Prehypertension, Stage 1 Hypertension and Stage 2 Hypertension. Equal number of male and female subjects (â‰¥22). All subjects between 18 and 65 years old.</td>
    </tr>
  </tbody>
</table>
:ET